6
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T9597 | H2S Donor 5a | Endogenous Metabolite | |
H2S Donor 5a is a H2S donor that could mimic the slow and continuous H(2)S generation process. | |||
T76545 | Cys(Npys)-TAT (47-57) | ||
Cys(Npys)-TAT (47-57), a peptide fragment corresponding to the transduction domain of the TAT peptide, features an activated cysteine residue C and is capable of electrostatically interacting with plasmid DNA. Notably, T... | |||
T36614 | DL-Sulforaphane N-acetyl-L-cysteine | ||
Nrf2 activation of the antioxidant response element (ARE) is central to cytoprotective gene expression against oxidative and/or electrophilic stress. Unless activated by inflammatory, environmental, or oxidative stressor... | |||
T60432 | NAAA-IN-3 | ||
NAAA-IN-3 (Compound 17a) is a potent and selective NAAA inhibitor with an IC50 of 50 nM. NAAA is a cysteine amidase which preferentially hydrolyzes the endogenous biolipids palmitoylethanolamide (PEA) and oleoylethanola... | |||
T70128 | Olmutinib hydrochloride | ||
Olmutinib is a novel third-generation epidermal growth factor receptor (EGFR) mutation-specific tyrosine kinase inhibitor, used in the treatment of T790M mutation positive non-small cell lung cancer. Olmutinib covalently... | |||
T65598 | Cefminox sodium | ||
Cefminox (Sodium) is a new cephamycin antibiotic possessing a D-amino acid moiety derived from D-cysteine at the C-7B side chain. Cefminox is active against a wide range of bacteria, especially Gram-negative and anaerobi... |